Skip to main content

Table 4 Distribution of overall extrahepatic metastases of HCC on FDG PET CT in 56 patients

From: Extrahepatic metastases of hepatocellular carcinoma on 18F FDG PET CT

Site of involvement

FDG-positive lesions

FDG-negative lesions

Both FDG-positive and FDG-negative lesions

Total

n (%)

n (%)

n (%)

n(%)

Lung

4 (7.14%)

14 (25%)

13 (23.21%)

31/56 (55.3%)

Skeletal

17 (30.36%)

1 (1.79%)

0

18/56(32.1%)

Peritoneum

0

2 (3.57%)

0

2/56(3.5%)

Brain

1 (1.79%)

0

0

1/56(1.79%)

Spleen

1 (1.79%)

0

0

1/56 (1.79%)

Adrenal gland

5 (8.93%)

2 (3.57%)

0

7/56(12.5%)

Muscle

1 (1.79%)

0

0

1/56 (1.79%)

Lymphnodal metastases

 

 Regional lymph nodes

15 (26.79%)

5 (8.93%)

5 (8.93%)

25/56 (44.65%)

 Distant lymph nodes

14 (25%)

5 (8.93%)

3 (5.36%)

22/56 (39.2%)